Can cognitive function tests discriminate between patients with glioma and healthy controls prior to treatment? A systematic review.

Can cognitive function tests discriminate between patients with glioma and healthy controls prior to treatment? A systematic review.

Show other versions (1)

<h4>Background</h4>Brain tumours affect 7 per 100,000 people in the UK, glioma being most prevalent, with only 12% five-year survival rates and devastating impacts. Primary care triage tools could facilitate earlier detection of glioma. One option for triage is cognitive function testing...

Full description

Saved in:
Bibliographic Details
Main Authors: Laura Standen, Aiman Aslam, Roisin Curran, Christina Derksen, Dharani Yerrakalva, Daisy McInnerney, Paul M Brennan, Fiona M Walter, Suzanne E Scott
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0329663
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1371/journal.pone.0329663

Similar Items